DNAnexus and Panomics Unite for Biopharma Excellence
In the ever-evolving landscape of biopharma, data plays a pivotal role in shaping advancements and innovations. DNAnexus, a leader in precision health data management, and Panomics, renowned for AI-powered omics data discovery, have announced a collaborative initiative aimed at revolutionizing how biopharma organizations approach multi-omics data analysis.
Enhancing Data Analysis Workflows
This partnership is set to dramatically enhance transcriptomics and proteomics workflows, fundamental for biomarker discovery and drug repurposing efforts. By integrating Panomics’ sophisticated interactive data analysis tools with DNAnexus’ robust Cohort Browser, researchers will now have access to a powerful suite of solutions that streamline complex data analyses.
Interactive Multi-Omics Tools
With the incorporation of advanced analytics capabilities, biopharma researchers will be able to perform large-scale and interactive analyses within a secure, compliant cloud-based environment. This innovation enables the dynamic filtering, visualization, and querying of intricate multimodal data sets, which is crucial for uncovering valuable patterns and actionable insights.
A Statement from Leadership
Radu Andrei Tanasa, the visionary founder and CEO of Panomics, emphasized the transformational potential of this partnership: “DNAnexus has built the world’s most secure precision health data platform for biopharma enterprises. The combination of our technologies will enable researchers to conduct real-time analyses that will not only accelerate drug discovery timelines but also simplify the identification of potential repurposing candidates by searching for shared biological signatures.”
DNAnexus' Strong Footprint in the Industry
Today, DNAnexus proudly serves over 45,000 registered users spanning 48 countries. The company actively manages a staggering 105 petabytes of intricate clinical, genomic, proteomic, and multi-omic datasets for its growing network of collaborators. Their enterprise platform stands distinguished by its adherence to the highest industry standards for data quality and regulatory compliance.
Advancing Precision Health with Collaboration
Commenting on this strategic endeavor, Thomas Laur, the CEO of DNAnexus, stated, “This collaboration is another example of how we continue to enhance our platform, providing our customers with advanced tools necessary to unlock the invaluable insights contained within massive multi-omic datasets.”
About Panomics
Founded in 2022, Panomics is a pioneering biotechnology research company committed to transforming the biopharmaceutical landscape. By integrating diverse data sets from genomics, transcriptomics, proteomics, and metabolomics, Panomics endeavors to foster deeper insights into biological systems. Their state-of-the-art SaaS and PaaS platform is designed to revolutionize how biopharma entities manage, process, and extract meaningful data from complex multi-omics samples.
About DNAnexus
DNAnexus is renowned as the enterprise platform for precision health data, dedicated to propelling the development, approval, and delivery of personalized therapies. With over 15 years of expertise in bioinformatics and genomics, DNAnexus drives a connected data ecosystem that leaders in precision health trust for actionable insights. This flexible ecosystem ensures that omics and real-world data remain accessible and secure, ultimately enhancing patient care and outcomes.
Frequently Asked Questions
What collaborative effort was recently announced?
DNAnexus and Panomics have partnered to create a comprehensive multi-omics data management and analysis solution aimed at biopharma organizations.
How will this collaboration benefit biopharma researchers?
The collaboration will enhance workflows for transcriptomics and proteomics, allowing researchers to conduct interactive analyses and uncover valuable insights more efficiently.
What is the significance of multi-omics data?
Multi-omics data integrates various biological datasets, helping researchers in biomarker discovery and drug repurposing, enabling better-targeted therapies.
How many users does DNAnexus serve globally?
DNAnexus currently has over 45,000 registered users across 48 countries, managing extensive multi-omic datasets.
What is Panomics known for?
Panomics is recognized for its innovative suite of tools for AI-driven omics data management, founded to enhance the understanding of biological systems since 2022.
